Access our Plans and Tools
NWHRN creates plans and tools to help partners be prepared and resilient
- This event has passed.
Monoclonals and More: Issues and Opportunities with Early COVID-19 Treatment Options
November 12, 2021 @ 9:30 am - 11:00 am
In the Updated COVID-19 Treatment Guidelines on Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection when there are Logistical or Supply Constraints, the COVID-19 Treatment Guidelines Panel recommends the use of anti-SARS-CoV-2 monoclonal antibodies (mAbs) for individuals who are at high risk for progression to severe COVID-19.
Presenters on this webinar will review some of the most current recommendations for use of mAbs and upcoming therapies and the challenges and opportunities that they may pose in conjunction with mAb and other treatments (e.g., prioritization and distribution). Speakers will also highlight operational principles for a scaled strategy for use of these therapeutics in a scarce resource situation.
More information can be found on this flyer.